Bevacizumab Not Effective in Advanced Lung Cancer in the Elderly – Medscape

by lowes1 on April 20, 2012


Health Newstrack
Bevacizumab Not Effective in Advanced Lung Cancer in the Elderly
Medscape
April 17, 2012 — The addition of the targeted therapy bevacizumab (Avastin, Genentech) to standard chemotherapy for advanced nonsmall cell lung cancer (NSCLC) did not significantly increase survival rates for patients 65 years and older, according to
Avastin No Help in Advanced NSCLCMedPage Today
Adding Drug to Standard Chemotherapy Provides No Survival Benefit for Older Newswise (press release)
Study examines drug regimen for the treatment of non-small cell lung cancer Science Codex
The Oncology Report -PLoS Blogs (blog) -Medical News Today
all 21 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: